Affiliation:
1. Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University
2. First Affiliated Hospital of Xi'an Jiaotong University
3. Xi'an Jiaotong University
Abstract
Abstract
Although many studies have reported the relationship between female hormone intake and the coronary artery disease(CAD) development their association has not been elucidated and defined. Based on data from the Third National Health and Nutrition Examination Survey, this study assessed the relation between female hormone intake and the CAD development in 38745 eligible female participants. Many sociocultural determinants of health (SDOH) factors are significantly related to CAD occurrence and female hormone intake. Stratified analysis of SDOH factors showed that female hormone intake reduces the risk of CAD in women aged ≥ 60 years old. For women who received higher levels of education, female hormone intake is a risk factor for CAD. For women in poverty or wealth, female hormone intake is a risk factor for congestive heart failure and stroke, but it is a protective factor for the four clinical features of CAD for women in middle-income levels. Moreover, for women with menarche at 13–15 years old, menopause at 30–49 years old, and pregnancies 7–9 times, as well as with a low-sugar, low-fat, low-cholesterol diet and proper folic acid intake, female hormone intake have a protective effect on the development of CAD. We conclude that the appropriate female hormone intake plays a protective role in the occurrence of CAD, but it also exerts an adverse effect on CAD under a different SDOH background. It suggested that the patients must be rigorously screened for SODH background in clinical applications of female hormones to exert a protective effect on CAD.
Publisher
Research Square Platform LLC
Reference51 articles.
1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study;Roth GA;J Am Coll Cardiol,2020
2. Genetics of coronary artery disease: discovery, biology and clinical translation;Khera AV;Nat Rev Genet,2017
3. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017;Dai H;Eur Heart J Qual Care Clin Outcomes,2022
4. Immunity and Inflammation in Atherosclerosis;Wolf D;Circ Res,2019
5. Hyperglycemia Drives Stent Restenosis in STEMI Patients;Mone P;Diabetes Care,2021